Ventricular Assist Devices (MCP-1602) - Global Industry Analysts, Inc.

Research Abstract

This report analyzes the worldwide markets for Ventricular Assist Devices in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for the period of 2006 through 2015. A five-year historic analysis is also provided for these markets. The report profiles 28 companies including many key and niche players worldwide such as Abiomed, Inc., Berlin Heart GmbH, EvaHeart Medical USA, Inc., HeartWare Limited, Jarvik Heart, Inc., MEDOS Medizentechnik AG, MicroMed Cardiovascular, Inc., SynCardia Systems, Inc., Terumo Heart, Inc., Thoratec Corporation, Ventracor Limited, and World Heart Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code :	MCP-1602
Price :	$3950
Companies :	28

Pages :	168
Date :	February 2009
Market Data Tables :	66

Complimentary Copy of Study Findings:

Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.

VENTRICULAR ASSIST DEVICES (Complete Report)

Pages : 168

$3950

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

$100

Study Reliability and Reporting Limitations.....I-1

Disclaimers.....I-2

Data Interpretation & Reporting Level.....I-2

Quantitative Techniques & Analytics.....I-3

Product Definitions and Scope of Study.....I-3

II. EXECUTIVE SUMMARY

$2250

1. Introduction.....II-1

$500

Global & Regional Market Analysis.....II-1

Opportunities in VAD Market.....II-1

Destination Therapy – An Immense Potential Opportunity.....II-1

$100

Next Generation Devices to Offer Pronounced Scope.....II-2

Heart Transplantation Scenario.....II-2

Table 1: Number of Heart Transplants Worldwide (2000-2006) (In Units) (includes corresponding Graph/Chart).....II-2

$300

Table 2: Heart Transplants Worldwide (2008E): Percentage Share Breakdown by Country/Region (includes corresponding Graph/Chart).....II-3

$300

2. Competition.....II-4

$300

Thoratec is the Clear Leader.....II-4

Leading Players in the Global VAD Market.....II-4

Table 3: Leading Players in the Global VAD and Circulatory Support Market (2007): Percentage Breakdown of Value Sales for Thoratec, Abiomed, WorldHeart and Others (includes corresponding Graph/Chart).....II-4

Table 4: Global VAD Market (2007): Implantations in Units by Select Player – Thoratec, MicroMed Cardiovascular, Berlin Heart, Ventracor, Terumo Heart and HeartWare (includes corresponding Graph/Chart).....II-4

$300

Competition Heats Up.....II-5

Competitive Technologies.....II-5

$100

3. VAD – An Insight.....II-6

$800

Heart – The Vital Organ.....II-6

Heart Diseases.....II-6

Congenital Heart Disease.....II-6

Congestive Heart Failure.....II-6

Mechanical Circulatory Support Systems.....II-6

Total Artificial Heart.....II-6

$100

VADs.....II-7

VADs Usage by Indication and Time Duration.....II-7

$100

Types.....II-8

VAD Components.....II-8

VAD Pumps.....II-8

$100

Li-Ion Batteries: Reliable Power Sources for Portable Medical Devices.....II-9

Implantation Procedure.....II-9

Aftercare.....II-9

$100

Complications.....II-10

Infection.....II-10

Internal Bleeding.....II-10

Thrombus.....II-10

Table 5: Percentage Breakdown of Possible Complications in VADs Usage by Type – Infection, Bleeding, Arrhythmia, Renal Dysfunction, Respiratory Dysfunction, Neurologic Dysfunction, RV Dysfunction and Others (includes corresponding Graph/Chart).....II-10

$300

Pricing of VAD.....II-11

Table 6: Average Selling Prices of Select VADs by Company and Model.....II-11

VAD Improvisations.....II-11

$300

LVADs – An Introduction.....II-12

LVAD Milestones.....II-12

$100

An Effective Therapeutic Device for End-Stage Congestive Heart Failure.....II-13

Ventricular Assistance Vs. Heart Replacement.....II-13

$200

4. An Insight into the First, Second and Third Generation VADs.....II-15

$200

First Generation VAD.....II-15

Second Generation VAD.....II-15

Rotary Axial Flow Pumps.....II-15

$100

Drawbacks of Axial Flow Pump.....II-16

Third Generation VAD.....II-16

$100

Select First, Second and Third Generation Implantable VADs.....II-17

$100

5. Reimbursement Scenario.....II-18

$100

Government Regulations.....II-18

The US.....II-18

Canada.....II-18

Europe.....II-18

$100

6. Product Approvals/Innovations/Introductions.....II-19

$300

Thoratec Receives FDA Approval for its HeartMate II LVAS.....II-19

HeartWare Receives Conditional Approval for its HeartWare LVAS.....II-19

Abiomed Receives CE Mark for AB5000 Portable Driver.....II-19

Ventracor Receives USFDA Approval to Use its VentrAssist Device in Clinical

Trials.....II-19

$100

NewCorTec Launches a New LVAD.....II-20

WorldHeart Launches New Pediatric VAD.....II-20

Ventracor Obtains FDA Approval for VentrAssist’s US BTT Trial.....II-20

MicroMed Cardiovascular Obtains 5-Year CE Mark Extension for DeBakey.....II-20

Thoratec Submits PMA for HeartMate II Left Ventricular Assist System.....II-20

Ventracor Receives ‘Commercial Ready’ Grant to Develop VentrAssist LVAD.....II-20

$100

Terumo Heart Obtains CE Mark for its DuraHeart® LVAS in Europe.....II-21

Abiomed Acquires Regulatory Approval in Australia for Impella LP 2.5 LVAD.....II-21

Abiomed Receives FDA Approval for Impella 2.5 VAD Pilot Trials.....II-21

Biophan Develops New MYO-VAD.....II-21

$100

Queensland University of Technology Invents Counter-Flow Pump.....II-22

HeartWare Obtains German Regulatory Approval for its HVAD™.....II-22

Abiomed Receives Regulatory Approval in France for its AB5000 VAD.....II-22

MiTi Develops MitiHeart LVAD for Heart Failure Patients.....II-22

$100

MicroMed Cardiovascular’s ‘DeBakey VAD Child’ Receives FDA Approval.....II-23

$100

7. Recent Industry Activity.....II-24

$300

UPMC Wins Gold Seal of Approval™ to Use VADs in Destination Therapy.....II-24

E-Wilson Acquires 97% of the MicroMed Cardiovascular’s Outstanding Shares.....II-24

World Heart Enters into Partnership with Abiomed.....II-24

$100

Thoratec Corporation Enters into Agreement with Levitronix.....II-25

World Heart Implants First Rotary VAD.....II-25

Abiomed Unveils a New Educational as well as Service Program.....II-25

$100

MicroMed Technology Merges with Salmon Express.....II-26

Abiomed Acquires Impella CardioSystems.....II-26

Thoratec Announces 40% Increase in Medicare Refund on VADs Used in DT.....II-26

National Heart, Lung and Blood Institute Awards Contract worth $6.95 Million.....II-26

$200

8. Focus on Select Global Players.....II-28

$300

Abiomed, Inc. (USA).....II-28

Berlin Heart GmbH (Germany).....II-28

EvaHeart Medical USA, Inc. (USA).....II-28

HeartWare Limited (Australia).....II-28

Jarvik Heart, Inc. (USA).....II-28

$100

MEDOS Medizentechnik AG (Germany).....II-29

MicroMed Cardiovascular, Inc. (USA).....II-29

SynCardia Systems, Inc. (USA).....II-29

Terumo Heart, Inc. (USA).....II-29

Thoratec Corporation (USA).....II-29

$100

Ventracor Limited (Australia).....II-30

World Heart Corporation (USA).....II-30

$100

9. Global Market Perspective.....II-31

Table 7: World Recent Past, Current & Future Market Analysis for Ventricular Assist Devices by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-31

Table 8: World Historic Review for Ventricular Assist Devices by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....II-31

$300

Table 9: World 10-Year Perspective for Ventricular Assist Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-32

$300

III. MARKET

$1950

1. The United States.....III-1

$975

A. Market Analysis.....III-1

Heart Ailments – The Death Sentence.....III-1

Table 10: Incidence, Prevalence and Deaths due to Heart Ailments in the US (2007) (includes corresponding Graph/Chart).....III-1

Huge Waiting Time for Heart Transplant.....III-1

$150

VADs for Heart Failures.....III-2

Table 11: VAD Market in the US: Percentage Breakdown by Indication: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery and Others (includes corresponding Graph/Chart).....III-2

Market Dynamics.....III-2

High Selling Price.....III-2

Drug Industry Poses Intense Competition.....III-2

$150

Lack of Timely and Quick FDA Approvals.....III-3

Reimbursement.....III-3

CMS Increases LVAD Coverage for Heart Patients.....III-3

$75

New Facility Criteria to Hospitals on VAD Implantation for Destination

Therapy.....III-4

Competition.....III-4

Table 12: Leading Players in the US Bridge-to-Transplant VAD Market (2008E) - Percentage Breakdown of Sales for Thoratec and Others.....III-4

$150

Table 13: Leading Players in the US destination therapy VAD Market (2007): Percentage Breakdown of Sales for Thoratec and Others.....III-5

Product Approvals/Innovations/Introductions.....III-5

$300

Strategic Corporate Developments.....III-7

$225

Key Players.....III-10

$150

B. Market Analytics.....III-12

Table 14: US Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-12

$150

Table 15: US Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-13

$150

2. Europe.....III-14

$675

A. Market Analysis.....III-14

Competitive landscape.....III-14

Next-generation VADs in Europe by Company (2007).....III-14

Table 16: Heart Transplants and Patients Waiting List in Europe (2005-2007): Figures in Units (includes corresponding Graph/Chart).....III-14

$150

Belgium.....III-15

Reimbursement Scenario.....III-15

Key Data.....III-15

Table 17: Belgium VAD Market (2002-2005): Implants in Units (includes corresponding Graph/Chart).....III-15

Table 18: Belgium VAD Market (2002-2005): BTT Implants in Units (includes corresponding Graph/Chart).....III-15

$150

Table 19: Belgium VAD Market (2004-2005): BTT Implants in Units by Device – Incor, Excor, Novacor, Thoratec, Medos, and TCI HM (includes corresponding Graph/Chart).....III-16

Germany.....III-16

The United Kingdom.....III-16

$150

Product Approvals/Innovations/Introductions.....III-17

$75

Strategic Corporate Development.....III-18

Key Players.....III-18

$75

B. Market Analytics.....III-19

Table 20: European Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-19

$150

Table 21: European Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-20

$150

3. Rest of World.....III-21

$275

A. Market Analysis.....III-21

Product Innovations/Approvals.....III-21

Strategic Corporate Development.....III-21

Key Players.....III-21

$75

B. Market Analytics.....III-22

Table 22: Rest of World Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-22

$150

Table 23: Rest of World Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-23

$150

IV. COMPETITIVE LANDSCAPE

103

$995

Total Companies Profiled: 28 (including Divisions/Subsidiaries - 31)
Region/Country                 Players

The United States                20
Japan                             2
Europe                            7
     Germany                      3
     The United Kingdom           1 
     Italy                        1
     Rest of Europe               2
Asia-Pacific (Excluding Japan)    2

Click here to request a full table of contents and more details on this project.

VENTRICULAR ASSIST DEVICES - A GLOBAL STRATEGIC BUSINESS REPORT

Research Abstract

Complimentary Copy of Study Findings:

TABLE OF CONTENTS

VENTRICULAR ASSIST DEVICES - A GLOBAL STRATEGIC BUSINESS REPORT stLight.options({ publisher:'12345' });

Research Abstract

Complimentary Copy of Study Findings:

TABLE OF CONTENTS

VENTRICULAR ASSIST DEVICES - A GLOBAL STRATEGIC BUSINESS REPORT